Irl B. Hirsch, MD - Program Co-Chair
University of Washington School of Medicine
Davida F. Kruger, MSN, APN-BC, BC-ADM - Program Co-Chair
Henry Ford Health System
Mark Atkinson, PhD
University of Florida
Robert H. Eckel, MD
University of Colorado
Alison B. Evert, MS, RD, CDE
University of Washington
Carla J. Greenbaum, MD
Benaroya Research Institute
Janet B. McGill, MD, MA, FACE
Washington University in St. Louis
Camille Powe, MD
Massachusetts General Hospital
Michael C. Riddell, PhD
York University
Elizabeth Seaquist, MD
University of Minnesota
Linda M. Siminerio, RN, PhD, CDE
University of Pittsburgh
Jill A. Weissberg-Benchell, PhD, CDE
Northwestern University
Carol Wysham, MD
Rockwood Clinic PS
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
- Irl B. Hirsch, MD (Co-Chair), has served as a consultant for Abbott Laboratories; and received grant funding from Beta Bionics and Insulet Corporation.
- Carla J. Greenbaum, MD has served as an advisory board member for Merck, GentiBio; Enthera Sciences, VieloBio, and Altheia Science; as consultant for AstraZeneca; and received grant funding from Bristol-Myers Squibb, Jansen Pharmaceuticals, Pfizer Inc., ProventionBio, and Intrexon.
- Janet B. McGill, MD, MA, FACE has served as an advisory board member for Bayer Inc., Eli Lilly & Company. Mannkind Corporation, and Novo Nordisk; as a consultant for Boehringer Ingelheim and Gilead; and received grant funding from Dexcom, Medtronic Minimed, Novo Nordisk, and Beta Bionics.
- Michael C. Riddell, PhD has served as an advisory board member for Eli Lilly & Company and Zealand.
- Carol Wysham, MD has received grant funding from Abbott Laboratories, Corcept, Eli Lilly & Company, Novo Nordisk, and Regeneron Pharmaceuticals.
The following faculty reported no relevant financial relationships: Mark Atkinson, PhD, Robert H. Eckel, MD, Alison B. Evert, MS, RD, CDE, Camille Powe, MD, Elizabeth Seaquist, MD, Linda Siminerio, PhD, and Jill A. Weissberg-Benchell, PhD, CDE.
The following committee member who planned and reviewed content for this activity reported relevant financial relationships:
- Davida F. Kruger, MSN, APN-BC, BC-ADM (Co-Chair), has served as an advisory board member for Sanofi, Novo Nordisk, and Modular Medical.
- Irl B. Hirsch, MD (Co-Chair), has served as a consultant for Abbott Laboratories; and received grant funding from Beta Bionics and Insulet Corporation.
The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by educational grant from Abbott Diabetes Care, Dexcom, Lilly USA, Novo Nordisk, Insulet Corporation, Medtronic Diabetes, Provention Bio, and Tandem Diabetes.